We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USFD icon
776
US Foods
USFD
$24B
$1.14M 0.01%
25,045
+17,806
+246% +$736K
MTCH icon
777
Match Group
MTCH
$8.55B
$1.13M 0.01%
31,035
+3,758
+14% +$127K
SKX
778
DELISTED
Skechers
SKX
$1.13M 0.01%
18,132
-597
-3% -$32.2K
ALKS icon
779
Alkermes
ALKS
$8.25B
$1.13M 0.01%
40,610
+37,961
+1,433% +$986K
PCH
780
DELISTED
PotlatchDeltic
PCH
$1.12M 0.01%
22,900
+18,072
+374% +$828K
ACA icon
781
Arcosa
ACA
$7.11B
$1.12M 0.01%
13,548
+10,160
+300% +$746K
MORN icon
782
Morningstar
MORN
$7.53B
$1.12M 0.01%
3,909
+3,388
+650% +$883K
BURL icon
783
Burlington
BURL
$23.2B
$1.12M 0.01%
5,736
+43
+0.8% +$6.42K
CYTK icon
784
Cytokinetics
CYTK
$10.4B
$1.12M 0.01%
13,360
+6,548
+96% +$237K
PBW icon
785
Invesco WilderHill Clean Energy ETF
PBW
$461M
$1.11M 0.01%
37,465
+37,148
+11,719% +$1.03M
UCO icon
786
ProShares Ultra Bloomberg Crude Oil
UCO
$385M
$1.11M 0.01%
42,607
+28,945
+212% +$874K
VRNS icon
787
Varonis Systems
VRNS
$5B
$1.11M 0.01%
24,538
+22,608
+1,171% +$851K
EPRT icon
788
Essential Properties Realty Trust
EPRT
$6.62B
$1.11M 0.01%
43,418
+28,946
+200% +$671K
ALTR
789
DELISTED
Altair Engineering Inc
ALTR
$1.1M 0.01%
13,122
+11,641
+786% +$810K
BIO icon
790
Bio-Rad Laboratories Class A
BIO
$9.42B
$1.1M 0.01%
3,414
+2,636
+339% +$826K
PCVX icon
791
Vaxcyte
PCVX
$8.64B
$1.1M 0.01%
17,549
+16,386
+1,409% +$851K
HAE icon
792
Haemonetics
HAE
$4B
$1.09M 0.01%
12,790
+10,917
+583% +$944K
EGUS icon
793
iShares ESG Aware MSCI USA Growth ETF
EGUS
$28.6M
$1.09M 0.01%
32,415
-2,751
-8% -$86.2K
AVAV icon
794
AeroVironment
AVAV
$9.45B
$1.09M 0.01%
8,650
+8,303
+2,393% +$1.02M
COHR icon
795
Coherent
COHR
$74.2B
$1.09M 0.01%
25,038
+20,151
+412% +$726K
CTLT
796
DELISTED
CATALENT, INC.
CTLT
$1.09M 0.01%
24,254
+15,428
+175% +$624K
UHS icon
797
Universal Health Services
UHS
$10.5B
$1.09M 0.01%
7,131
+2,289
+47% +$308K
ESNT icon
798
Essent Group
ESNT
$6.33B
$1.09M 0.01%
20,599
+13,108
+175% +$641K
XRAY icon
799
Dentsply Sirona
XRAY
$2.43B
$1.08M 0.01%
30,474
+17,764
+140% +$564K
SANM icon
800
Sanmina
SANM
$10.9B
$1.08M 0.01%
21,082
+17,675
+519% +$902K

Similar funds

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.